A Phase 4 interventional study of Strong African American Families Program and Strong African American Families--Teen Program in Adolescent Alcohol Use, sponsored by University of Georgia. Completed. Open to participants aged 11 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-19.
Sponsored by University of Georgia · Phase 4, Interventional, and Prevention
The most common approach to preventing alcohol use involves providing a well-designed program in preadolescence just prior to or upon entering middle school. This approach does not have long-lasting effects or address the risk factors that lead many youth to use alcohol in high school. This study tested a strategy that compares offering effective programs at the transition to middle school and the transition to high school with only offering a program at either one of the transitions or no programs at all.
Alcohol use is a leading cause of morbidity and mortality among high school students. Annually, underage drinking leads to more than 3,000 deaths and 2.6 million other harmful events, resulting in $5.4 billion in medical costs, $14.9 billion in work loss and other resource costs, and $41.6 billion in lost quality of life. This public health crisis has engendered considerable attention from prevention scientists, who have specified guidelines for the development of primary prevention programs and the timing of their implementation. The present research is based on critical limitations in the prevailing model for implementing primary prevention for alcohol use. This model focuses on delaying alcohol use onset among youth who begin use in middle school (ages 11-14). Based on studies that linked early use to a high-risk behavioral trajectory in adolescence, prevention scientists translated data on risk and protective processes for early-onset alcohol use into primary prevention programs for youth to be implemented during or just prior to the transition to adolescence. This model has informed numerous randomized prevention trials and investigations of prevention implementation. An unquestioned premise of this model involves the adequacy of a single preadolescent "inoculation" of prevention programming to protect youth into the high school years.
The proposed trial addresses empirical and theoretical limitations to the preadolescent/single inoculation paradigm. First, inclusive reviews reveal that primary prevention programs implemented in early adolescence fail to achieve robust, long-term results. Second, studies of alcohol use trajectories reveal patterns of onset in high school with rapid escalation that culminate in high levels of alcohol use. Third, in the prevailing paradigm, targeting early adolescent risk processes is assumed to be sufficient to equip youth for the novel risk processes they will encounter in high school. In contrast, this study investigates the proposition that achievement of public health impact requires a "dual-inoculation" prevention strategy, one that addresses both onset in early adolescence and mid-adolescence and provides developmentally tailored curricula at each transition.
Based on longitudinal studies with rural African American families that documented the changing context of alcohol use risk and protective processes from late childhood through adolescence, scientists at the Center for Family Research developed a series of developmentally appropriate, family-centered preventive interventions that have proven efficacious in in preventing alcohol use: the Strong African American Families (SAAF) program for youth age 10-12 and the SAAF-Teen program for youth age 14-16. These programs afford a unique opportunity to test dual-inoculation hypotheses. Unlike medical inoculations of a vaccine, it is not appropriate to give the same inoculation to an 11-year-old that one gives a 14-year-old. Rather, each preventive inoculation must be tailored to address the most salient risk and protective processes at particular developmental transitions.
This study will recruit a sample of 460 African American families into a four-arm randomized prevention trial and evaluate the differential alcohol prevention effects of (a) a dual inoculation of prevention (youth receive SAAF at age 11 and SAAF-Teen at age 14) compared with (b) receipt of a preadolescent inoculation (SAAF at age 11), (c) receipt of a mid-adolescent inoculation (SAAF-Teen at age 14), or (d) a minimal contact control.
Specific efficacy aims are to:
Investigate the intervening processes that account for the relative efficacy of a dual inoculation. Specifically, we expect that intervention-targeted early adolescent protective processes, early adolescent alcohol use outcomes, and intervention-targeted mid-adolescent protective processes will account for group differences in alcohol use in high school.
To facilitate the potential dissemination of a dual inoculation approach, this study investigates the cost-effectiveness of a dual inoculation relative to preadolescent, mid-adolescent, or control conditions.
The specific cost-effectiveness aim is to:
Exclusion Criteria:
participants in this arm receive the SAAF intervention at age 11-12.
Behavioral: Strong African American Families Program
participants in this arm receive the SAAF-Teen intervention at age 14-15.
Behavioral: Strong African American Families--Teen Program
participants in this arm receive SAAF at age 11-12 and later receive SAAF-Teen at age 14-15
Behavioral: Strong African American Families Program · Behavioral: Strong African American Families--Teen Program
These participants receive no interventions.
SAAF is a 7 session family skills training program
Also known as: SAAF
SAAF-T is a 5 session family skills training program
Also known as: SAAF--T
Alcohol use in past 3 months (single item)
Youth complete this single item from Monitoring the Future Study assessing the frequency of alcohol use in the past 3 months. There is an ordinal response scale ranging from 0 (none) to 6 (30 or more times). Higher response numbers indicate a worse outcome (more alcohol use).
Time frame: 3 months
Frequency of cannabis use in the past 3 months (single item)
Single item from Monitoring the Future Study assessing frequency of marijuana use in the past 3 months. There is an ordinal response scale ranging from 0 (none) to 6 (30 or more times). Higher responses indicate a worse outcome (more marijuana use in the past 3 months).
Time frame: 3 months
Monitoring the Future: Total substance use (summative index of use of alcohol, cannabis, and nicotine)
Youth complete 3 single items from the Monitoring the Future study indexing the frequency of their use of alcohol, cannabis, and nicotine in past 3 months. There is an ordinal response scale ranging from 0 (none) to 6 (30 or more times) for each item. The three items are summed yielding a scale ranging from 0-18. Higher response numbers indicate a worse outcome (more substance use).
Time frame: 3 months
Center for Epidemiological studies-Depression scale
Parent complete this 20 item measure of depressive symptoms. Responses to each item are on a scale from 0 to 3; responses are summed. Items are summed. Scores range from 0-60 with higher scores indicate more depressive symptoms in the past week (a worse outcome).
Time frame: Past 7 days
The National Survey of Adolescents Conduct Problems Subscale
Youth complete a 15 Item scale from the National Survey of Adolescents which refer to different conduct problems. Youth provide the number of times they enacted each behavior in the past 3 months. These responses are summed. Scores can range from 0-99 with higher scores indicating more engagement in conduct problems.
Time frame: past 3 months
Center for Epidemiological Studies-Depression Scale-Child Version
Youth complete this 20 item measure of depressive symptoms. Responses to each item are on a likert scale from 0 to 3; responses are summed. Scores range from 0-60 with higher scores indicate more depressive symptoms in the past week (a worse outcome).
Time frame: past 7 days
No study locations are listed for this record.
Plan to share: No — Participants have not consented to data being shared outside of research team
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Georgia